NYSE$HNGE
Hinge Health Inc · Q2 2026 earnings
Q2 2026 earnings · · After market close · Investor relations
Briefing
Hinge Health Inc reported record Q2 2026 results with 53% revenue growth and a definitive agreement to acquire Cylinder Health.
Hinge Health delivered strong Q2 2026 performance with revenue of $212.8 million, up 53% year-over-year, and free cash flow reaching $99.6 million. GAAP operating income turned positive at $40.4 million while non-GAAP operating income grew 136% to $61.5 million. The company raised full-year 2026 revenue guidance and announced expansion into gastrointestinal care via the Cylinder Health acquisition.
- Revenue grew 53% year-over-year to $212.8 million driven by high member conversion and new program adoption.
- Free cash flow more than tripled to $99.6 million while GAAP net income reached $43.7 million.
- Signed definitive agreement to acquire Cylinder Health for $105 million, expanding into GI care with launch planned for 2027.
- Raised full-year 2026 revenue guidance to $856-860 million (46% growth) and increased share repurchase authorization to $496.5 million.
Headline financials
Revenue & EPS history
Hinge Health, Inc. · Revenue · Quarterly
$213M
Forward guidance
Company raised full-year 2026 revenue guidance to $856-860 million reflecting 46% growth and non-GAAP operating income of $236-244 million.
Tailwinds
- Q3 2026 revenue expected $223-225 million (45% YoY growth)
- Full-year non-GAAP operating margin expected at 28%
- Acquisition of Cylinder Health expands platform into GI care
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports
+7.3%
Avg return
Earnings day
+9.1%
Avg return
5 days after
+15.0%
Avg return
30 days after
75%
3 / 4 earnings
Positive
+17.3%
Q4 2025
Best reaction
-1.6%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q1 2026 | +2.4% | +15.3% | +29.3% | |
| Q4 2025 | +17.3% | +17.8% | +36.2% | |
| Q3 2025 | -1.6% | +2.8% | -2.5% | |
| Q2 2025 | +11.3% | +0.3% | -3.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro